Literature DB >> 33822278

[New botulinum toxins for aesthetic dermatology : A comprehensive review].

A Patil1, M Kassir2, U Wollina3, M Goldust4.   

Abstract

Facial rejuvenation is gaining immense popularity among patients and clinicians. Botulinum toxins derived from bacteria are well-tolerated options as minimally invasive interventions for facial rejuvenation or other aesthetic procedures. These products have revolutionized aesthetic treatments. Several types of botulinum toxins (BoNT) are available. Currently type A and B are clinically used and only BoNT‑A products are approved for use for cosmetic indications in the Germany and the United States. Each product is unique in terms of its composition. Understanding the various BoNT‑A products is essential in choosing the optimal treatment for our patients. In this article we discuss different BoNT‑A products used for aesthetic intervention.

Entities:  

Keywords:  Esthetic medicine; Hyperkinetic facial lines; Indications; Rejuvenation; Safety

Year:  2021        PMID： 33822278     DOI： 10.1007/s00105-021-04801-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  51 in total

Review 1.  An overview of the cosmetic treatment of facial muscles with a new botulinum toxin.

Authors:  Luitgard G Wiest
Journal:  Acta Dermatovenerol Croat       Date:  2009       Impact factor: 1.256

Review 2.  The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems.

Authors:  Raj Kumar; Harkiran Preet Dhaliwal; Roshan Vijay Kukreja; Bal Ram Singh
Journal:  Semin Neurol       Date:  2016-02-11       Impact factor: 3.420

Review 3.  A review of the longevity of effect of botulinum toxin in wrinkle treatments.

Authors:  G Wright; A Lax; S B Mehta
Journal:  Br Dent J       Date:  2018-02-23       Impact factor: 1.626

Review 4.  Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.

Authors:  Sara A Kaltreider; Robert H Kennedy; John J Woog; Elizabeth A Bradley; Philip L Custer; Dale R Meyer
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

5.  Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.

Authors:  Nicholas J Lowe; Aadarsh Shah; Philippa L Lowe; Rickie Patnaik
Journal:  J Cosmet Laser Ther       Date:  2010-04       Impact factor: 2.247

Review 6.  The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.

Authors:  Alastair Carruthers; Michael A C Kane; Timothy C Flynn; Peter Huang; Sang D Kim; Nowell Solish; Gina Kaeuper
Journal:  Dermatol Surg       Date:  2013-03       Impact factor: 3.398

Review 7.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

8.  Botulinum Toxin: Non-cosmetic Indications and Possible Mechanisms of Action.

Authors:  Uwe Wollina
Journal:  J Cutan Aesthet Surg       Date:  2008-01

Review 9.  New neurotoxins on the horizon.

Authors:  Scott R Freeman; Joel L Cohen
Journal:  Aesthet Surg J       Date:  2008 May-Jun       Impact factor: 4.283

Review 10.  Clinical relevance of botulinum toxin immunogenicity.

Authors:  Reiner Benecke
Journal:  BioDrugs       Date:  2012-04-01       Impact factor: 5.807
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.